Cargando…

Mesenchymal Stem Cell Administration in Patients with Chronic Obstructive Pulmonary Disease: State of the Science

Patients with chronic obstructive pulmonary disease (COPD) have chronic, irreversible airway inflammation; currently, there is no effective or curative treatment and the main goals of COPD management are to mitigate symptoms and improve patients' quality of life. Stem cell based therapy offers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Shih-Lung, Lin, Ching-Hsiung, Yao, Chao-Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337878/ https://www.ncbi.nlm.nih.gov/pubmed/28303154 http://dx.doi.org/10.1155/2017/8916570

Ejemplares similares

From Biomarkers to Novel Therapeutic Approaches in Chronic Obstructive Pulmonary Disease
por: Wang, Hsu-Hui, et al.
Publicado: (2021)

Performance and Clinical Utility of Various Chronic Obstructive Pulmonary Disease Case-Finding Tools
por: Chen, Chiung-Zuei, et al.
Publicado: (2021)

Comparison of Effectiveness Using Different Dual Bronchodilator Agents in Chronic Obstructive Pulmonary Disease Treatment
por: Cheng, Shih-Lung
Publicado: (2021)

Preclinical Studies of Mesenchymal Stem Cell (MSC) Administration in Chronic Obstructive Pulmonary Disease (COPD): A Systematic Review and Meta-Analysis
por: Liu, Xiangde, et al.
Publicado: (2016)

Effects of Wharton's jelly-derived mesenchymal stem cells on chronic obstructive pulmonary disease
por: Cho, Jun Woo, et al.
Publicado: (2019)

Elevated placenta growth factor predicts pneumonia in patients with chronic obstructive pulmonary disease under inhaled corticosteroids therapy
por: Cheng, Shih-Lung, et al.
Publicado: (2011)

The Impact of the Age, Dyspnoea, and Airflow Obstruction (ADO) Index on the Medical Burden of Chronic Obstructive Pulmonary Disease (COPD)
por: Li, Chin-Ling, et al.
Publicado: (2022)

Cardiovascular and respiratory dysfunction in chronic obstructive pulmonary disease complicated by impaired peripheral oxygenation
por: Chuang, Ming-Lung, et al.
Publicado: (2015)

Factors responsible for poor sleep quality in patients with chronic obstructive pulmonary disease
por: Chang, Chih-Hao, et al.
Publicado: (2016)

Regulation of transplanted mesenchymal stem cells by the lung progenitor niche in rats with chronic obstructive pulmonary disease
por: Zhang, Wan-Guang, et al.
Publicado: (2014)

Chronic obstructive pulmonary disease and asthma: mesenchymal stem cells and their extracellular vesicles as potential therapeutic tools
por: Abbaszadeh, Hossein, et al.
Publicado: (2022)

The Relationship between Exertional Desaturation and Pulmonary Function, Exercise Capacity, or Medical Costs in Chronic Obstructive Pulmonary Disease Patients
por: Tsai, Meng-Lin, et al.
Publicado: (2023)

The Effectiveness and Tolerability of Glycopyrronium for Patients with Chronic Obstructive Pulmonary Disease in a Clinical Setting: GLARE-Taiwan
por: Huang, Wei-Chang, et al.
Publicado: (2022)

A review of omalizumab for the management of severe asthma
por: Lin, Ching-Hsiung, et al.
Publicado: (2016)

Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts
por: Cheng, Shih-Lung, et al.
Publicado: (2016)

COPD Guidelines in the Asia-Pacific Regions: Similarities and Differences
por: Cheng, Shih-Lung, et al.
Publicado: (2021)

Leukocyte Mitochondrial DNA Copy Number Is Associated with Chronic Obstructive Pulmonary Disease
por: Liu, Shih-Feng, et al.
Publicado: (2015)

Patterns of Oxygen Pulse Curve in Response to Incremental Exercise in Patients with Chronic Obstructive Pulmonary Disease – An Observational Study
por: Chuang, Ming-Lung, et al.
Publicado: (2017)

Stem cell therapy for chronic obstructive pulmonary disease
por: Chen, Yun-Tian, et al.
Publicado: (2021)

Evaluation of epithelial mesenchymal transition in patients with chronic obstructive pulmonary disease
por: Sohal, Sukhwinder S, et al.
Publicado: (2011)

Explainable Machine Learning Model for Predicting First-Time Acute Exacerbation in Patients with Chronic Obstructive Pulmonary Disease
por: Kor, Chew-Teng, et al.
Publicado: (2022)

Comparing Clinical Outcomes of Tiotropium/Olodaterol, Umeclidinium/Vilanterol, and Indacaterol/Glycopyrronium Fixed-Dose Combination Therapy in Patients with Chronic Obstructive Pulmonary Disease in Taiwan: A Multicenter Cohort Study
por: Hsieh, Meng-Jer, et al.
Publicado: (2022)

Effects of bone marrow-derived mesenchymal stem cell transplantation on chronic obstructive pulmonary disease/obstructive sleep apnea overlap syndrome in rats
por: Chen, Min, et al.
Publicado: (2019)

Effects of TRPC1 on epithelial mesenchymal transition in human airway in chronic obstructive pulmonary disease
por: Xu, Feng, et al.
Publicado: (2017)

Using Health Administrative Data to Predict Chronic Obstructive Pulmonary Disease Exacerbations
por: Jiang, Lili, et al.
Publicado: (2020)

Investigating the relationships among lung function variables in chronic obstructive pulmonary disease in men
por: Chuang, Ming-Lung, et al.
Publicado: (2019)

Mechanisms affecting exercise ventilatory inefficiency-airflow obstruction relationship in male patients with chronic obstructive pulmonary disease
por: Chuang, Ming-Lung
Publicado: (2020)

Superiority of pulmonary administration of mepenzolate bromide over other routes as treatment for chronic obstructive pulmonary disease
por: Tanaka, Ken-Ichiro, et al.
Publicado: (2014)

Role of epithelial mesenchymal transition (EMT) in chronic obstructive pulmonary disease (COPD)
por: Sohal, Sukhwinder Singh, et al.
Publicado: (2013)

The paradoxical response to short-acting bronchodilator administration in patients with chronic obstructive pulmonary disease
por: Shin, Hong-Joon, et al.
Publicado: (2021)

Sputum myeloperoxidase in chronic obstructive pulmonary disease
por: Zhu, Alling, et al.
Publicado: (2014)

Potential Therapeutic Strategy in Chronic Obstructive Pulmonary Disease Using Pioglitazone-Augmented Wharton's Jelly-Derived Mesenchymal Stem Cells
por: Park, Jin-Soo, et al.
Publicado: (2019)

Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD
por: Cheng, Shih-Lung, et al.
Publicado: (2017)

Blood monocyte levels predict the risk of acute exacerbations of chronic obstructive pulmonary disease: a retrospective case–control study
por: Lin, Ching-Hsiung, et al.
Publicado: (2022)

Chronic obstructive pulmonary disease treated with inhaled medium- or high-dose corticosteroids: a prospective and randomized study focusing on clinical efficacy and the risk of pneumonia
por: Cheng, Shih-Lung, et al.
Publicado: (2014)

Synergic Effect of Early Administration of Probiotics and Adipose-Derived Mesenchymal Stem Cells on Alleviating Inflammation-Induced Chronic Neuropathic Pain in Rodents
por: Chen, Kuan-Hung, et al.
Publicado: (2022)

The impact of 2011 and 2017 Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) guidelines on allocation and pharmacological management of patients with COPD in Taiwan: Taiwan Obstructive Lung Disease (TOLD) study
por: Hsieh, Meng-Jer, et al.
Publicado: (2018)

Mesenchymal stromal cells: a novel therapy for the treatment of chronic obstructive pulmonary disease?
por: Broekman, Winifred, et al.
Publicado: (2018)

Roles of Mesenchymal Cells in the Lung: From Lung Development to Chronic Obstructive Pulmonary Disease
por: Nasri, Amel, et al.
Publicado: (2021)

Allogeneic umbilical cord-derived mesenchymal stem cell transplantation for treating chronic obstructive pulmonary disease: a pilot clinical study
por: Le Thi Bich, Phuong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cksu07t868te2p8t4nuqvrp9d1